Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, Matsushita Y, Matsushita M, Wakita M, Misawa S, Idei M, Miida T, Tamura N, Takahashi K, Naito T.
Hiki M, et al. Among authors: matsushita m, matsushita y.
PLoS One. 2021 Apr 6;16(4):e0249449. doi: 10.1371/journal.pone.0249449. eCollection 2021.
PLoS One. 2021.
PMID: 33822809
Free PMC article.
Clinical Trial.